ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $233,000 | -60.9% | 3,694 | -54.9% | 0.01% | -47.1% |
| Q1 2021 | $596,000 | +156.9% | 8,194 | +121.8% | 0.02% | +88.9% |
| Q4 2020 | $232,000 | +18.4% | 3,694 | +22.2% | 0.01% | -10.0% |
| Q4 2019 | $196,000 | +102.1% | 3,023 | -16.8% | 0.01% | +66.7% |
| Q3 2019 | $97,000 | +102.1% | 3,634 | +97.9% | 0.01% | +100.0% |
| Q2 2019 | $48,000 | +60.0% | 1,836 | -28.9% | 0.00% | +50.0% |
| Q4 2018 | $30,000 | -38.8% | 2,583 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $49,000 | +308.3% | 2,583 | -67.7% | 0.00% | +50.0% |
| Q4 2016 | $12,000 | – | 8,002 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |